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Objective: To examine the longitudinal association between pain and suicidal ideation in the general adult 
population. 
Method: Data were used from two waves (baseline and three-year follow-up) of the Netherlands Mental Health 
Survey and Incidence Study-2. Persons without prior 12-month suicidal ideation at baseline were included in this 
study (N=5,242). Pain severity and interference due to pain in the past month were measured using the 36-item 
Short Form Health Survey. Suicidal ideation and DSM-IV mental disorders were assessed using the Composite 
International Diagnostic Interview. Logistic regression analyses were performed. 
Results: Moderate to very severe pain (OR 3.39, p <.001) and moderate to very severe interference due to pain 
(OR 2.35, p .01) were associated with a higher risk for incident suicidal ideation at follow-up after adjustment for 
baseline sociodemographic variables and mental disorders. No interaction effects were found between pain 
severity or interference due to pain and mental disorders.  
Conclusion: Moderate to severe pain and interference due to pain are risk factors for suicidal ideation 
independently of concomitant mental disorders. We suggest taking assessment and management of suicidal 
ideation in patients with pain into account both in clinical treatment as well as in suicide prevention action plans. 
 
Keywords:  





Every year, approximately 800,000 people die by suicide worldwide [1], and is thus a major public health problem. 
A suicide attempt is preceded by suicidal ideation, and the risk of a suicide attempt is highest in the first year after 
ideation [2,3]. Understanding which factors contribute to suicidal ideation might, therefore, help in improving 
suicide prevention plans.  
Although chronic pain is mentioned as an important risk factor for suicidal behavior (including ideation) in a WHO 
report [4], many European countries have developed suicide prevention plans that only take mental disorders into 
account [5], and not pain. Pain occurs in 19% of the adult European population [6]. In severe cases [7-10], if 
treatment is no longer effective, one of the choices to end pain might be to commit suicide [11]. Hence, the 
association of pain with suicidal ideation is a relevant public health problem. However, the current evidence on 
the size of this association is limited and is mostly based on clinical, retrospective or cross-sectional studies [7,10]. 
More importantly, these studies did not control for concomitant mental disorders, that have a known association 
with suicidal ideation. Several other, cross-sectional, studies did control for the presence of common mental 
disorders, and demonstrated a significant link between pain and suicidal ideation [12-14].  Unfortunately, data 
regarding the longitudinal association of pain with suicidal ideation in the general population is more scarce. 
One longitudinal, population-based study, investigating the association between headache and suicidal ideation in 
adults, shows a 1.5-fold increased risk of suicidal ideation in those reporting headache, after adjustment for menal 
disorders (i.e. depressive, anxiety and substance use disorders [15]. A more recent longitudinal, population-based 
study,  found similar results in a population sample of adolescents, in which those reporting headache had a 1.5-
fold increased risk of subsequent suicidal ideation, after adjustment of depression [16]. As these studies focused 
only on headaches in the adult population [15] and on chronic pain in the adolescent population [16], the 
association of pain in general with subsequent suicidal ideation in the general adult population, over and above 
common mental disorders, still needs further exploration. To gain insight into the interplay of physical pain and 
suicidal ideation we need longitudinal population-based research, exploring the role of pain in the development of 
suicidal ideation, taking mental disorders into account that have a known association with suicidal ideation.  
We will explore the influence of pain characteristics in general (pain severity and interference with normal 
activities due to pain) on subsequent suicidal ideation in the adult general population, using data of the Netherlands 
Mental Health Survey and Incidence Study-2 (NEMESIS-2). Although it would be of interest to study the influence 
of pain on a wider range of suicidal behavior (including plans and attempts), the most frequent suicidal behavior 




hypothesize that subjects with more severe pain and subjects with more interference due to pain are at increased 
risk for suicidal ideation compared to subjects without pain, in an adult general population sample. Furthermore, 
we hypothesize that this association will be stronger in subjects with a mental disorder compared to subjects 
without a mental disorder.  
 
2. Material and Methods 
2.1 Study design and participants 
Data were used from the first two waves of NEMESIS-2, a psychiatric epidemiological cohort study among the 
Dutch general population aged 18–64 years at baseline [17]. Design and methods of the NEMESIS-2 study are 
described elsewhere [17], but a brief summary is given here. The NEMESIS-2 study is based on a multistage, 
stratified random sampling of households, with one respondent randomly selected in each household. The sample 
was nationally representative, although younger subjects were somewhat under-represented. The Medical Ethics 
Committee for Institutions on Mental Health Care (METIGG) approved the study. After having been informed 
about the study objective, respondents provided written informed consent.  
See Figure 1 for a flowchart of the inclusion procedure. In the first wave (T0), performed from November 2007 to 
July 2009, a total of 6,646 persons were interviewed (response rate 65.1%; average interview duration 95 min). 
The interviews were laptop computer assisted and almost all were held at the respondent’s home. All T0 
respondents were approached for follow-up (T1) three years after T0, from November 2010 to June 2012. Of this 
group, 5,303 persons were re-interviewed (response rate 80.4%, excluding those deceased; average interview 
duration 84 min). The mean period between both interviews was three years and seven days. Baseline 
psychopathology was not significantly associated with attrition at follow-up, after controlling for 
sociodemographics [18], compared to other studies that did find such an association [19-21]. Furthermore, in the 
cohort used for this study (i.e. those without 12-month suicidal ideation at baseline), pain characteristics at baseline 
were not significantly associated with attrition at follow-up, after controlling for demographics. 
For this study, those persons without 12-month suicidal ideation at T0 were selected (N=5,242). Lifetime previous 
suicidal ideation was not an exclusion criterion if in the last 12 months at baseline no suicidal ideation was reported.  
 
2.2 Outcome 




Suicidal ideation was assessed using the Suicidality Module of the Composite International Diagnostic Interview 
(CIDI) version 3.0, a fully structured lay-administered diagnostic interview of mental disorders and suicidality 
[22]. The CIDI was developed and adapted for use in the World Mental Health Survey Initiative. In the 
Netherlands, the CIDI 3.0 was first used in ESEMeD [3], which is part of this initiative. The CIDI 3.0 version used 
in NEMESIS-2 was an improvement of the one used in the Dutch ESEMeD study. At baseline, respondents were 
asked about previous experiences of suicidal ideation (“Have you ever seriously thought about committing 
suicide?”), suicide plans (“Have you ever made a plan for committing suicide?”) and suicide attempts (“Have you 
ever attempted suicide?”). The respondents received a ‘respondent booklet’, in which these suicidal experiences 
were listed as A (suicidal ideation), B (suicidal plans), and C (suicidal attempt). Subsequently, if a respondent 
answered with yes, it was asked how old that person was when they first had such an experience, and whether they 
had this experience in the last 12 months. At T1, respondents were asked the same questions about suicidal 
ideation, but then the time period referred to suicidal ideation they had experienced since the baseline interview.  
 
2.2.2 Pain assessments 
At baseline, pain severity was assessed using a question from the SF-36-item Short Form Health Survey [24,25]: 
“How much pain did you experience in the past four weeks?” Respondents could choose between “no pain”, “very 
little pain”, “little pain”, “moderate pain”, “severe pain” and “very severe pain”. Due to the small number of 
subjects in the moderate, severe, and very severe pain categories, grouping these categories together into one 
answer category was needed to create more equal groups. Therefore, the categories used in this study were: 0 = no 
pain, 1 = very little pain, 2 = little pain, 3 = moderate to very severe pain. 
Interference due to pain was measured with the SF-36 question: “How much interference did you experience with 
normal activities (including work outside household, and domestic work) in the past four weeks as a consequence 
of pain?”. Respondents could choose between “no interference”, “little interference”, “moderate interference”, 
“much interference” and “very much interference”. Due to the small number of subjects in the moderate, much, 
and very much interference categories, we grouped these categories into one answer category to create more equal 
groups. Therefore, the categories used in this study were: 0 = no interference, 1 = little interference, 2 = moderate 






The covariates included in this study are: 1) sociodemographic variables (including sex, age in categories (18–24, 
25–34, 35–44, 45–54, 55–64), education (primary, lower secondary, higher secondary, higher 
professional/university), living situation (with partner or not), and working situation (having a paid job or not)); 
2) twelve-month prevalence of mental disorders at baseline (as measured with the CIDI version 3.0 [22], including 
any mood disorder (major depression, dysthymia, bipolar disorder), any anxiety disorder (panic disorder, 
agoraphobia, social anxiety disorder, generalized anxiety disorder, specific disorder), and any substance use 
disorder (alcohol/drug abuse and dependence)); and 3) prior suicidal ideation (more than 12 months prior to 
baseline). Research has demonstrated acceptable reliability and validity for assessing the common mental disorders 
[26]. 
 
2.3 Statistical methods 
First, univariate analyses were performed to describe the sample at baseline, regarding sociodemographics, mental 
disorders, pain severity and interference due to pain. Second, logistic regression analyses were performed with 
four models to examine both the risks of pain severity and pain interference on suicidal ideation at follow-up: 
model 1 shows the unadjusted odds ratios (OR); model 2 shows s  the ORs adjusted for demographics;  model 3, 
shows the ORs adjusted for demographics, any 12-month mood disorder, any 12-month anxiety disorder, and any 
12-month substance use disorder at baseline; model 4 shows the ORs adjusted for all the covariates as in model 3, 
and for lifetime suicidal ideation. In all models, persons with no pain and persons with no interference due to pain 
were selected as the reference category. To test for linear trends, potential determinants (i.e. pain severity and 
interference due to pain) were also modelled separately as continuous variables in all models (p for trend test).  In 
order to detect modifying or interaction effects, an additive model was used (guided by previous work, see e.g.: 
[27,28]). Additive interaction exists if the combined effect of pain and a common mental disorder on suicidal 
ideation is stronger than the sum of the separate effects. Additive interaction effects were estimated by comparing 
the ORs of pain and the common mental disorder combined with the expected value in case of no interaction. If 
the expected OR, that is OR(AB) ≈ OR(A) + OR(B) – 1, lays below the lower limit of the confidence interval of 
the combined effect, additive interaction is assumed [29,30]). In total, we tested six interaction effects: pain 
severity by mood disorder, by anxiety disorder and by substance use disorder as well as interference due to pain 
by mood disorder, by anxiety disorder and by substance use disorder on suicidal ideation. For these analyses, pain 
severity was dichotomized into moderate to very severe pain (1) versus no to little pain (0). Interference due to 




testing procedures were used in all analyses with 0.05 alpha levels, except the interaction analyses, where an alpha 
of 0.001 was used. All statistical analyses were performed with Stata version 12.1, using weighted data (weighted 
with the variables sex, age, partner status (living with or without partner), educational level, degree of urbanization, 
working situation, and country of birth) to ensure they were representative of the national population. Robust 
standard errors were calculated to obtain correct 95% confidence intervals and p values [31]. 
 
3. Results 
Table 1 describes the baseline characteristics of the 5,242 persons in this cohort. In all, 50.6% were men and most 
of the participants were 35 years of age or older. Of the total participant group, 68% had a partner and 76.9% had 
a job. Most subjects (41.8%) attended higher secondary school, whereas 7.1% of the subjects had only attended 
primary school. Most subjects (83.1%) did not have any 12-month mood, anxiety or substance use disorders, 
whereas 5.5% reported any mood disorder, 10.0% any anxiety disorder and 5.3% any substance use disorder in 
the past 12 months. Of the cohort, 14.8% experienced moderate to very severe pain, 26.0% reported very little to 
little pain and 59.2% reported having no pain in the past month. Regarding interference due to pain in the month 
before baseline, 8.1% had moderate to very severe interference, 14.2% reported little interference and 77.7% 
reported no interference. 
Table 1: Sociodemographics, pain characteristics (severity and interference), and mental disorders in the 
general population among the total sample, those without 12-month suicidal ideation, and those with 
suicidal ideation, at baseline 
  Total sample 
(N=5242)                      
No suicidal ideation 
at follow-up 
(n=5149) 
Suicidal ideation at 
follow-up (n=93)                               
  n (%) % % 
Gender Male 2351 (50.6) 50.6 48.5 
 Female 2891 (49.4) 49.4 51.5 
Age 18–24 349 (11.9) 11.9 13.5 
 25–34 843 (20.0) 19.9 21.4 
 35–44 1361 (24.5) 24.7 18.5 
 45–54 1290 (23.3) 23.1 31.6 
 55–64 1399 (20.3) 20.4 15.1 
Education Primary 222 (7.1) 6.8 19.5 
 Lower secondary 1370 (22.3) 22.2 26.9 
 Higher secondary 1707 (41.8) 42.0 30.4 
 Higher professional/university 1943 (28.9) 29.0 23.2 
Living situation Without partner 1595 (32.0) 31.8 39.7 




Working situation No job 1257 (23.1) 22.7 42.3 
 Job 3985 (76.9) 77.3 57.7 
Pain severity* None 3071 (59.2) 59.7 35.0 
 Very little 618 (12.0) 12.0 11.8 
 Little 777 (14.0) 14.0 13.9 
 Moderate to very severe 775 (14.8) 14.3 39.2 
Pain interference** None 4010 (77.7) 78.1 55.6 
 Little 794 (14.2) 14.1 23.6 
 Moderate to very severe 436 (8.1) 7.8 20.8 
12-month (mood, anxiety or 
substance use) disorder 
No 12-month (mood, anxiety or 
substance use) disorder 
4408 (83.2) 83.9 47.4 
 Any 12-month (mood, anxiety or 
substance use) disorder 
834 (16.8) 16.1 52.6 
12-month mood disorder No 12-month mood disorder 4954 (94.5) 95.0 69.4 
 Any 12-month mood disorder 288 (5.5) 5.0 30.6 
12-month anxiety disorder No 12-month anxiety disorder 4731 (90.0) 90.5 63.5 
 Any 12-month anxiety disorder 511 (10.0) 9.5 36.5 
12-month substance use disorder No 12-month substance use disorder 5024 (94.7) 94.8 91.7 
 Any 12-month substance use 
disorder 
281 (5.3) 5.2 8.3 
* n=5,241 due to missing data of 1 person on pain severity; ** n=5,240 due to missing data of 2 persons on pain 
interference 
Data are presented in unweighted numbers and weighted percentages for the total sample (N=5242), and in 
weighted percentages for those reporting no suicidal ideation at follow-up (n=5149) and those reporting suicidal 
ideation at follow-up (n=93) 
 
At follow up, 93 subjects (1.8%) reported suicidal ideation. Of these 93 subjects, 17 made a suicide plan and of 
these 17 subjects who made a plan 9 also made a suicide attempt. Table 2 shows the odds ratios (OR) of pain 
severity at baseline with suicidal ideation three years later. In all models of pain severity, only the category of 
moderate to very severe pain was significantly associated with incident suicidal ideation three years later. In the 
unadjusted model (model 1), individuals with moderate to very severe pain had almost a five times higher OR for 
suicidal ideation than individuals without pain (OR 4.68, 95% CI 2.65-8.23). When controlling for demographics 
(model 2), the OR slightly decreased to a four times higher OR for suicidal ideation (OR 4.00, 95% CI 2.08-7.70), 
and when also controlling for any 12-month mood disorder, any 12-month anxiety disorder, and any 12-month 
substance use disorder (model 3), the OR for suicidal ideation was still more than three times higher (OR 3.39, 
95% CI 1.74-6.61) for those with moderate to very severe pain compared to individuals without pain. The p for 
trend showed that with higher pain severity, the risk of suicidal ideation significantly increased (models 1, 2, and 





Table 2: Odds ratios with 95% confidence intervals for the association between pain severity at baseline 
and suicidal ideation three years later among those without 12-month suicidal ideation at baseline  
 Model 1  Model 2  Model 3  Model 4  
 OR (95% CI) P-value OR (95% CI) P-value OR (95% CI) P-value OR (95% CI) P-value 
Pain severity         
0 (none) (ref)         
1 (very little) 1.70 (.68-4.21) .25 1.68 (.70–3.99) .24 1.69 (.72–4.00) .23 1.67 (.68-4.10) .26 
2 (little) 1.70 (.83-3.45) .14 1.73 .91–3.31) .10 1.43 (.74–2.79) .29 1.57 (.82-2.99) .17 
3 (moderate to very severe) 4.68 (2.65-8.23) <.001 4.00 (2.08–7.70) <.001 3.39 (1.74–6.61) <.001 2.69 (1.40-5.18) .003 
Covariates         
Gender Male (ref)         
 Female   .76 (.36-1.61) .47 .59 (.26-1.33) .20 .68 (.34-1.38) .28 
Age 18–24 (ref)         
 25–34   1.77 (.46-6.87) .40 1.71 (.42-6.90) .45 1.70 (.52-5.63) .38 
 35–44   2.66 (1.04-6.83) .04 2.34 (.86-6.37) .09 2.57 (.94-7.04) .07 
 45–54   1.77 (.82-3.79) .14 1.47 (.65-3.35) .35 1.49 (.68-3.24) .32 
 55–64   2.69 (1.15-6.31) .02 2.25 (.92-5.57) .07 2.11 (.92-4.84) .08 
Education Primary (ref)         
 Lower secondary   2.38 (.77-7.34) .13 2.65 (.89-7.88) .08 2.28 (.87-5.98) .09 









        
 Without partner   1.21 (.74-1.98) .44 .91 (.53-1.58) .75 .79 (.45-1.39) .41 
Working 
situation 
Job (ref)         




None (ref)         




None (ref)         




None (ref)         




No (ref)         
 Yes       6.48 (3.34-12.60) .001 




Model 1: unadjusted odds ratios 
Model 2: adjusted for demographics (gender, age, education, living situation, working situation) and time 
between measurements (T0–T1) 
Model 3: adjusted for demographics (gender, age, education, living situation, working situation), any mood 
disorder, any anxiety disorder, any substance use disorder, and time between measurements (T0–T1)  
Model 4: adjusted for demographics (gender, age, education, living situation, working situation), any mood 




Little interference due to pain (Table 3) was significantly associated with suicidal ideation compared to the 
reference category in the unadjusted model (model 1: OR 2.35, 95% CI 1.17-4.72)) and when adjusted for 
demographics only (model 2: OR 2.22, 95% CI 1.14-4.34). When also adjusted for mental disorders (model 3) and 
prior suicidal ideation (model 4), the association became non-significant (model 3: OR 1.74, 95% CI .81-3.74; 
model 4: OR 1.57). The category of moderate to very severe interference due to pain was significantly associated 
with suicidal ideation in all models: the OR was highest in the unadjusted model (model 1: OR 3.76; 95% CI 2.07-
6.82) and lowest in the fully adjusted model (model 4: OR 1.90, 95% CI 1.00-3.59). With more interference due 
to pain at baseline, the risk of suicidal ideation three years later significantly increased (p for trend in models 1 
and 2: <.001; in model 3: <.01; in model 4: <.05). 
 
Table 3: Odds ratios with 95% confidence intervals for the association between pain interference at 
baseline and suicidal ideation three years later among those without 12-month suicidal ideation at baseline  
 Model 1  Model 2  Model 3  Model 4  
 OR (95% CI) P-value OR (95% CI) P-value OR (95% CI) P-value OR (95% CI) P-value 
Pain interference         
0 (none) (ref)         
1 (little) 2.35 (1.17-4.72) .02 2.22 (1.14–4.34) .02 1.74 (.81–3.74) .15 1.57 (.72-3.43) .26 
2 (moderate to very severe) 3.76 (2.07-6.82) <.001 2.87 (1.64–5.02) <.001 2.35 (1.22–4.53) .01 1.90 (1.00-3.59) .05 
Covariates         
Gender Male (ref)         
 Female   .78 (.38-1.68) .56 .62 (.28-1.35) .23 .71 (.36-1.40) .32 
Age 18–24 (ref)         
 25–34   1.75 (.44-6.97) .42 1.62 (.39-6.71) .51 1.59 (.46-5.51) .46 
 35–44   2.66 (1.03-6.77) .04 2.33 (.84-6.50) .11 2.57 (.91-7.31) .08 
 45–54   1.76 (.79-3.70) .17 1.45 (.64-3.31) .37 1.47 (.68-3.19) .33 
 55–64   2.70 (1.14-6.27) .03 2.24 (.91-5.50) .08 2.18 (.94-5.05) .07 
Education Primary (ref)         
 Lower secondary   2.54 (.87-7.34) .09 2.76 (.95-8.00) .06 2.38 (.96-5.93) .06 












        
 Without partner   1.19 (.72-1.93) .51 .89 (.51-1.57) .69 .75 (.42-1.35) .34 
Working 
situation 
Job (ref)         




None (ref)         




None (ref)         




None (ref)         




No (ref)         
 Yes       6.92 (3.52-13.61) <.001 
P for trend 1.98 (1.51-2.61) <.001 1.75 (1.35-2.27) <.001 1.56 (1.14-2.13) .006 1.40 (1.02-1.93) .04 
Model 1: unadjusted odds ratios 
Model 2: adjusted for demographics (gender, age, education, living situation, working situation) and time 
between measurements (T0–T1) 
Model 3: adjusted for demographics (gender, age, education, living situation, working situation), any mood 
disorder, any anxiety disorder, any substance use disorder, and time between measurements (T0–T1) 
Model 4: adjusted for demographics (gender, age, education, living situation, working situation), any mood 





No interaction effects were found for any mood disorder with pain, any anxiety disorder with pain, and any 
substance use disorder with pain on the risk of suicidal ideation. These effects applied for both pain severity and 
interference due to pain. This implies that the association between pain and suicidal ideation did not significantly 
differ between subjects with and subjects without a mental disorder.  
 
4. Discussion 
The aim of this study was to explore the longitudinal influence of pain severity and interference due to pain 
occurring in the last month on subsequent suicidal ideation in the general adult population. We found that the risk 




experience more interference due to pain, which confirm our first hypothesis. These results did not change when 
adjusting for demographics and, more importantly, for concurrent mental disorders. In accordance with previous 
studies [16,32], adjusting for mental disorders did not significantly attenuate the observed risk of suicidal ideation. 
Our second hypothesis, that the association between pain and suicidal ideation would be stronger in subjects with 
a mental disorder, was not confirmed. The effect of pain on suicidal ideation did not differ between subjects with 
a mental disorder and subjects without a mental disorder. Our findings, therefore, show that pain is an important 
and unique risk factor for suicidal ideation, independent of mental disorders, and extend previous research by 
showing that more severe pain and more interference due to pain are risk factors for suicidal ideation at three-year 
follow-up in the general population, even when mental disorders are taken into account. Pain and suicidal ideation 
may share similar biological pathways that can explain our results. For example, a dysfunction in serotonin 
transmission, also implicated in pain, might ultimately lead to suicidal ideation [33,34]. More research on shared 
biological pathways between pain and mental disorder is needed to shed light on this issue.  
Our study found a higher OR than Calati et al. in their meta-analysis [7]; this may be related to the fact that the 
current study used a large nationally representative sample and had a longitudinal design, whereas Calati et al. [7]  
also included cross-sectional studies. This allows us to look at the incident suicidal ideation in persons with and 
without pain over time.  
 
4.1 Strengths and limitations 
Major strengths of this study are the longitudinal design and the large representative sample of the general 
population. Moreover, this is the first study to examine pain severity and interference due to pain as a risk factor 
for suicidal ideation in a large sample of the general population. This sample is representative of the general adult 
population (age 18-64 year), but might not be generalizable to other age categories, although comparable results 
were found in adolescents [16]. However, several limitations need to be noted as well. This study was based on 
self-reports, and suicidal ideation might therefore have been underreported. Furthermore, because we excluded 
individuals who experienced suicidal behavior more than 12 months prior to baseline, we could not report on the 
recurrence  of suicidal ideation. Whether pain might play a more important role in new onset or in recurrent suicidal 
ideation remains unknown. Future longitudinal research should take this into account, but this requires much larger 
samples with subjects reporting (new onset and recurrent) suicidal ideation at follow up. Additionally, it remains 
unknown whether pain also has an influence on other forms of suicidal behavior, such as plans and attempts. In 




prohibited us to study the influence of pain on other forms of suicidal behavior. A need exists, therefore, for studies 
which take these other forms of suicidal behavior into account. Regarding pain, we measured this with two items 
from the pain subscale of the SF36. A more comprehensive measurement of pain is preferred, in which more 
aspects of pain are distinguished, such as frequency/chronicity and cause or origin of pain. Regarding 
frequency/chronicity, the subjects in this study were asked to report pain severity and interference due to pain in 
the month before baseline, and although our results show a significant association of these pain variables with 
suicidal ideation in the following three years, a measurement of a longer duration of pain (e.g. chronic pain vs. 
acute pain) might result in stronger association with suicidal ideation [10,35]. Moreover, pain is not time 
independent and severity can change over time, affecting our results. For example, previous literature suggests 
that a change in severity of pain is associated with the course and severity of mental disorders [36,37], and it is 
therefore not unlikely that a change in pain severity could lead to a change in the risk of suicidal ideation (e.g. less 
severe pain over time might decrease the risk of suicidal ideation). However, in the present study, measurement 
of pain referred to pain in the four weeks prior to baseline. As the course of pain was not assessed in detail in 
NEMESIS-2 in the period between baseline and first follow-up, no inferences could, therefore, be made whether 
changes in the course of pain affected suicidal ideation. To differentiate pain trajectories, associated with suicidal 
ideation, we need to measure pain more comprehensively in future studies. The effect of this limitation is that we 
probably underestimate associations between pain and suicidality. It is conceivable that if we had restricted 
ourselves to a longer duration of pain at baseline or a measurement of increasing pain over time, we would have 
found even stronger associations with suicidal ideation at follow-up [10,35]. Regarding the cause or the origin of 
the pain, pain itself, of course, can be the trigger for a mental disorder, such as in a somatic symptom disorder 
[38]. However, there is a recent debate on whether this new DSM-5 diagnosis might lead to overpsychologizing 
and mislabeling pain [39]. Therefore, instead of making statements whether the experienced pain is part of a mental 
disorder, this study only focused on how severe the individual experienced the pain and how much interference 
due to pain there was. The experienced pain might also be explained as part of a more ‘somatic’ disease, such as 
cancer [40], cardiovascular disease [41], and rheumatoid arthritis [42]. It is often clinically difficult to tease out 
primary and secondary factors. In the present study, however, we did not know whether the experienced pain 
originated from a somatic disease. Furthermore, pain is highly associated with a variety of somatic diseases, and 
controlling for somatic diseases would then lead to overcorrection of the statistical model. An area of further study 
would be to consider to what extent pain is ‘mentally’ or ‘somatically’ attributable, and if so, to examine whether 




related coping (e.g. catastrophizing), might also play a mediating role in the link between pain and suicidal 
ideation, [43,44], but these were not studied here. In a study among 360 patients with rheumatic disease, less social 
support was associated with an increased risk for suicidal ideation [44], and in a sample of 1512 pain patients, 
catastrophizing was an important predictor of both the presence and severity of suicidal ideation, even after 
controlling for measures of affective function (e.g. depression, anxiety) [43]. In future research and treatment of 
pain, social support and catastrophizing as pain-related coping should be considered, as this may explain why pain 
predicts suicidality and can help designing strategies to prevent suicidal ideation. Furthermore, the course of 
mental disorders is diverse [45-47], and can be described as an incident, remitted, or chronic course. The literature 
shows that these different courses are associated with different courses of the severity of pain [36,37], making it 
of interest to study how different trajectories of mental disorders, next to different trajectories of pain, are 
associated with subsequent suicidal ideation. However, in the present study, no information was available on the 
exact time of onset of suicidal ideation. Therefore, we could not take interval mental disorders into account, as we 




Our finding that pain has a significant impact on suicidal ideation may be important for developing and 
customizing suicide prevention plans for patients suffering from pain [48]. To date, such plans mainly focus on 
mental disorders [5]. Patients with pain might also benefit from psychotherapeutic interventions, with a focus on 
building distress tolerance skills, challenging catastrophic thoughts, and instilling hope in the future. Pain 
medication can be an effective treatment for reducing pain symptoms and, therefore, might protect against 
developing suicidal ideation. However, caution is necessary, especially with opioid therapy: opioid deaths 
(including intentional suicides) are rising [49], and a higher dose of opioids increases the risk of suicide [50]. Two 
longitudinal studies [16,32] reported the increased risk of headaches and migraines on suicidal ideation/attempt 
versus controls. Our findings broaden this finding by including pain of any form – if severe or significant 
interference is experienced due to pain – as a risk factor for suicidal ideation. Therefore, the risk of suicidal ideation 
may need further discussion, even in the absence of common mental disorders when persons present themselves 
with severe pain or significant interference due to pain. More longitudinal research is needed that focuses on the 
role of pain in suicidal ideation, in which pain is measured more comprehensively, including pain location, origin 
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